As already discussed, the inhibition of ANGPTL3 and apoCIII are other promising therapeutic approaches to hypertriglyceridemia targeting these proteins with ribonucleic acid (RNA) interfering therapies are presently being exploited [16,79]. Here, APOC3 is linked to hypertriglyceridemia.